- Roche says it is thoughtful on token use for AI, shelves a drug from Carmot buyRoche has offered some insight into how it is using AI, from drug discovery to token use. AI has already contributed to “a significant increase in new molecules” in its pipeline, CEO Thomas Schin…Endpoints · 1d ago↗ source
- Exclusive: Obesity biotech Verdiva hires ex-Metsera CMO as crucial readouts nearLong-acting obesity pill developer Verdiva Bio has a new chief medical officer, and he comes from a biotech that was looking at very similar technology — and got bought for $10 billion not long ago…Endpoints · 1d ago↗ source
- Scancell to go public after winning reverse merger bid for troubled NeuphoriaScancell and Neuphoria have made their union official via a reverse merger that will result in a Nasdaq listing for Scancell and a resolution for Neuphoria’s shareholders after the biotech ended it…